| |
| |
|
| Insider
Information: |
Dethlefs Sven |
| Relationship: |
EVP, North America Com... |
| City: |
Petach Tikva |
| State: |
L3 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
165,381 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,312,026 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
165,381 |
|
|
| Total
Value |
$2,312,026 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Teva Pharmaceutical Industries L... |
TEVA |
EVP, North America Com... |
2023-03-07 |
165,381 |
2018-03-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
• – – |
2023-03-07 |
4 |
AS |
$9.43 |
$547,440 |
D/D |
(58,066) |
165,381 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
• – – |
2023-03-06 |
4 |
AS |
$9.93 |
$192,213 |
D/D |
(19,355) |
223,447 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
• – – |
2023-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,952 |
242,802 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
• – – |
2023-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
52,469 |
217,850 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
• – – |
2023-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
59,655 |
207,690 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
• – – |
2023-02-28 |
4 |
AS |
$9.89 |
$589,785 |
D/D |
(59,655) |
165,381 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
• – – |
2022-03-07 |
4 |
AS |
$7.37 |
$51,515 |
D/D |
(6,993) |
165,381 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
• – – |
2022-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,952 |
172,374 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
• – – |
2022-03-04 |
4 |
AS |
$7.48 |
$29,212 |
D/D |
(3,904) |
147,422 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
• – – |
2022-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
51,869 |
151,326 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
• – – |
2022-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,346 |
104,319 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
• – – |
2022-02-28 |
4 |
AS |
$8.14 |
$39,587 |
D/D |
(4,862) |
99,457 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
• – – |
2022-02-09 |
4 |
AS |
$9.06 |
$37,491 |
D/D |
(4,138) |
86,973 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
• – – |
2022-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,135 |
91,111 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP Global Marketing&Portfolio |
• – – |
2021-03-04 |
4 |
AS |
$10.57 |
$63,523 |
D/D |
(6,012) |
77,976 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP Global Marketing&Portfolio |
• – – |
2021-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,930 |
83,988 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP Global Marketing&Portfolio |
• – – |
2021-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,400 |
70,664 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP Global Marketing&Portfolio |
• – – |
2021-03-03 |
4 |
AS |
$10.86 |
$6,583 |
D/D |
(606) |
70,058 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP Global Marketing&Portfolio |
• – – |
2021-03-01 |
4 |
AS |
$10.83 |
$81,079 |
D/D |
(7,486) |
69,264 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP Global Marketing&Portfolio |
• – – |
2021-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,346 |
76,750 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP Global Marketing&Portfolio |
• – – |
2021-02-09 |
4 |
AS |
$12.69 |
$376,481 |
D/D |
(29,657) |
59,404 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP Global Marketing&Portfolio |
• – – |
2021-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
55,287 |
89,061 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP Global Marketing&Portfolio |
• – – |
2021-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,135 |
33,774 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP Global Marketing&Portfolio |
• – – |
2020-03-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,179 |
20,639 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP Global Marketing&Portfolio |
• – – |
2020-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,399 |
19,460 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
